Tag: Cardiac care

Low-cost blood test predicts cardiovascular event risk

Editor's Note A low-cost blood test for troponin, a protein released during heart muscle damage, significantly improves long-term risk prediction for heart attacks and strokes—especially in patients with intermediate cardiovascular risk, according to an April 7 report from News-Medical.Net. The findings, based on a large-scale international study led by the…

Read More

By: Matt Danford
April 11, 2025
Share

Dissolvable pacemaker delivers temporary cardiac support without wires, surgery

Editor's Note Researchers have developed a fully dissolvable, needle-injectable pacemaker that regulates heart rhythms without requiring surgical removal. As detailed in an April 2 article in Scientific American, the miniature device—just millimeters in size—can deliver electrical stimulation for days to weeks before safely breaking down in the body, potentially reducing…

Read More

By: Matt Danford
April 9, 2025
Share

Nurse-coordinated care reduces long-term heart risks after acute coronary syndrome

Editor's Note A nurse-coordinated prevention program significantly lowered the long-term risk of major adverse cardiovascular events (MACE) in adults recovering from acute coronary syndrome (ACS), according to an April 2 article in Healio. The program, which focused on lifestyle and behavioral changes, led to a 30% reduction in adverse events,…

Read More

By: Matt Danford
April 7, 2025
Share

The Joint Commission revises volume criteria for cardiac, stroke certifications

Editor's Note The Joint Commission announced significant updates taking effect immediately to the eligibility requirements for its cardiac and stroke certifications, developed in collaboration with the American Heart Association (AHA) and the American Stroke Association (ASA). According to the April 2 announcement,  key revisions involve the removal of percutaneous coronary…

Read More

By: Tarsilla Moura
April 2, 2025
Share

FDA issues Class 1 recall for vascular cannulas

Editor's Note Aortic root cannulas from Medtronic are the subject of the latest US Food and Drug Administration (FDA) class 1 recall, the most serious category reserved for risk of injury or death. Affected products include the DLP Aortic Root Cannula, MiAR Cannula, and DLP Aortic Root Cannula with Vent…

Read More

By: Matt Danford
April 1, 2025
Share

Cardiology efficiency, orthopedic revenue surge as ASCs navigate growing complexity

Editor's Note HST Pathways’ most recent industry report, discussed on the Advancing Surgical Care Podcast by HST CEO David Thawley and Bill Prentice, CEO of the Ambulatory Surgery Center Association (ASCA), offers insights into cardiology and orthopedic procedures done in ambulatory surgery centers (ASCs) in 2024, Ambulatory Surgery Center News…

Read More

By: Tarsilla Moura
March 26, 2025
Share

Smart t-shirt enables earlier discharge, safer recovery after urological cancer surgery

Editor's Note A wearable smart t-shirt that remotely monitors vital signs helped patients go home earlier and feel safer after robot-assisted urological cancer surgery, according to a March 21 article in Medical Xpress. The article details a pilot study, presented at the European Association of Urology Congress in Madrid, Spain,…

Read More

By: Matt Danford
March 25, 2025
Share

FDA designates Class 1 recall for embolization devices

Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…

Read More

By: Matt Danford
March 19, 2025
Share

Study: Miniature pacemakers for neonates, infants perform reliably for two years

Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…

Read More

By: Matt Danford
March 17, 2025
Share

Man survives 100 days with artificial titanium heart, setting new milestone

Editor's Note An Australian man lived for 100 days with an artificial titanium heart, the longest duration recorded for a patient using the device, according to a March 12 report from CNN. The breakthrough marks a significant step toward using total artificial hearts as a long-term solution for patients with…

Read More

By: Matt Danford
March 13, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat